Login
Register
Vetnosis publishes Pfizer-Fort Dodge Portfolio Conflict Analysis
Edinburgh, UK - 19th February 2009 - Vetnosis publishes Pfizer-Fort Dodge Portfolio Conflict Analysis
Vetnosis
has published the findings of its independent analysis of conflicts within the
Pfizer and Fort Dodge portfolios in a new multi-client study.
On
26 January Pfizer and Wyeth announced that they had entered into a definitive
merger agreement under which Pfizer will acquire Wyeth in a cash and stock
transaction worth $68 billion. This transaction combines Pfizer Animal Health
and Fort Dodge Animal Health to create the largest animal health company with sales of
£3.9 billion and about 20% market share.
However,
the large portfolios of Pfizer and Fort Dodge may present some regulatory and
commercial challenges due to portfolio conflicts in a number of key
categories. These challenges for Pfizer and Fort Dodge present
opportunities for other animal health companies looking to add strong brands to
their own portfolios.
This
multi-client study delivers a detailed qualitative Portfolio Conflict Analysis
for Pfizer and Fort Dodge in Australia, Canada, France, Germany, Italy, Spain,
UK and USA. We have drawn upon regulators own reports on previous
transactions to guide our market segmentation and portfolio conflict analysis.
The
deliverable includes a 71 page written report and a fully searchable Excel
dataset that identifies Portfolio Conflicts in each of these markets at a
product level. "Vetnosis has been able to undertake this detailed
portfolio conflict analysis extremely efficiently by using its veterinary
Portfolio Analysis Tool (vPAT-Online). This proprietary,
fully-searchable electronic database of licensed medicines marketed by every
animal health company in the leading animal health markets has proven to be
invaluable in its ability to analyse portfolios at the most granular level"
said Tim Evans, Managing Director of Vetnosis.
Adding
to this, Julie van den Driesche, Senior Analyst remarked, "Historically,
analysing vaccine portfolio conflicts was very time consuming, however,
vPAT-Online, allows us to search and identify vaccines with the same species
and antigen valency with only a few clicks making vaccine analysis simple,
accurate and fast."
For further information on the Pfizer-Fort Dodge Portfolio Conflict Analysis please contact Tim Evans.
Tim Evans
Managing Director
T: +44 (0)131 718 0772
Email: tim.evans@vetnosis.com
